Through their respective targeting of suppressor of cytokine signaling 3 (SOCS3) and protein inhibitor of activated STAT 3 (PIAS3), these miRNAs help induce the proliferation of early myeloid suppressor cells within breast cancer and exert a potent inhibitory influence on T cell immunity in both mice and humans (39). This evidence concerns the gene SOCS3 and breast carcinoma.